Issue : The Pharmaceutical Journal, June 2020, Vol 304, No 7938
Sort by: Newest first Oldest first A-Z Z-A
-
Investigational treatments for COVID-19
A review of several of the treatments for COVID-19 currently being trialled.
-
Blue, brown and now green Subscription
The ‘NHS long-term plan’ has called for a shift towards inhalers with a lower carbon footprint.
-
We need a national de-labelling drive for patients with penicillin allergy Subscription
False penicillin allergies are placing patients at risk of resistant infections and are a threat to antimicrobial stewardship; we must safely de-label patients to avoid these costs to public health.
-
How collaboration was key at the NHS Nightingale Hospital Yorkshire and the Humber Subscription
We were interested to read the article ‘The COVID-19 emergency hospitals: seizing the challenge’ in the May 2020 issue of The Pharmaceutical Journal, and here we report how working together across the hospitals in our area allowed the NHS Nightingale Hospital ...
-
Pharmacist-led medicines optimisation may reduce readmissions to hospital, study finds Subscription
Attending a pharmacist-led medicines optimisation clinic after hospital discharge could help to reduce patient readmissions, visits to A&E and unplanned GP consultations, a study published in the International Journal of Clinical Pharmacy has found.
-
What provisional registration will mean for the pharmacy profession Subscription
The COVID-19 pandemic has forced radical changes to how the 2020 class of preregistration trainees will transition into their careers.
-
BAME patients less likely to take up community pharmacy services in North West London Subscription
During the COVID-19 pandemic, the interplay between ethnicity and poor health outcomes has rightly come under scrutiny. A high proportion of those who have lost their lives to COVID-19 were from black, Asian and minority ethnic (BAME) groups.
-
Dexamethasone is ‘first drug’ to be shown to improve survival in COVID-19
Low-dose dexamethasone, a “widely available, safe and well-known drug”, is the first medicine to be shown to result in a “significant reduction in mortality” in those with COVID-19 requiring oxygen or ventilation, researchers have said.
-
Insomnia disorder: diagnosis and prevention Subscription
Insomnia can have a profound impact on a patient; understanding its causes and how it can be prevented can have significant implications on their wellbeing.
-
Pharmacy degree apprenticeships put on hold by COVID-19
Development of a pharmacy degree apprenticeship has been put on hold because of the COVID-19 pandemic, the body responsible for building healthcare workforce capacity has said.
Show 10 per page20 per page50 per page
